Target of replication: *A priori* experimental protocols, materials, and confirmatory analysis plans were peer reviewed, [pre-registered][1], and published by [*eLife*][2].
This component includes all primary and QC data for the first three protocols of the replication of [Liu et al. 2011][3]. These experiments include:
### Contents ###
[Figures component][4], contains a visualization of the results. These figures are the same as can be found in the Replication Study and include Figure 1 and Figure 1 - figure supplement 1, which display miR-34a expression and Flow cytometry gating strategy, respectively.
[Data Component][5], contains data generated from the experimental work related to the first three protocols which relate to the Expression of miR-34a in LAPC4 sub-populations.
[Methods Component][6], contains the methods relating to the first three protocols.
[Maintenance and purification of LAPC4 xenograft prostate tumors Component][7]
[Quality Control Component][8], contains the results of both STR profiling and mycoplasma testing related to these protocols.
[1]: https://osf.io/4psr3/
[2]: https://elifesciences.org/articles/06434
[3]: http://www.nature.com/articles/nm.2284
[4]: https://osf.io/grva2/wiki/home/
[5]: https://osf.io/5u9ed/wiki/home/?edit&view&menu
[6]: https://osf.io/exq24/wiki/home/?edit&view&menu
[7]: https://osf.io/4f3rq/wiki/home/?edit&view&menu
[8]: https://osf.io/6u42f/wiki/home/?edit&view&menu